{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T04:02:19Z","timestamp":1751860939271,"version":"3.41.0"},"reference-count":9,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2003,12,1]],"date-time":"2003-12-01T00:00:00Z","timestamp":1070236800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Card Electrophysiol Rev"],"published-print":{"date-parts":[[2003,12]]},"DOI":"10.1023\/b:cepr.0000023142.88884.d8","type":"journal-article","created":{"date-parts":[[2004,4,8]],"date-time":"2004-04-08T01:10:56Z","timestamp":1081386656000},"page":"372-373","source":"Crossref","is-referenced-by-count":0,"title":["Aspirin\u2014Anticoagulant Combination in Patients with Non Valvular Atrial Fibrillation Commentary on the FFAACS Study Results"],"prefix":"10.1007","volume":"7","author":[{"given":"Philippe P.","family":"Lechat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"5257228_CR1","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000047711","volume":"12","author":"P Lechat","year":"2001","unstructured":"Lechat P, Lardoux H, Mallet A, Sanchez P, Derumeaux G, Lecompte T, Maillard L, Mas Jean-Louis, Mentre F, Pousset F, Lacomblez L, Pisica G, Solbes Latourette S, Raynaud P, Chaumet-Riffaud P, for the FFAACS Investigators. Anticoagulant (Fluindione)-Aspirin combination in patients with high-risk atrial fibrillation. Cerebrovasc Dis 2001;12:245\u2013252.","journal-title":"Cerebrovasc Dis"},{"key":"5257228_CR2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJM199308193290802","volume":"329","author":"AGG Turpie","year":"1993","unstructured":"Turpie AGG, Gent M, Laupacis A, Latour Y, Gunstensen J, Basile F, Klimek M, Hirsh J: A comparison of aspirin with placebo in patients treated with warfarin after heart-valve replacement. N Engl J Med 1993;329:524\u2013529.","journal-title":"N Engl J Med"},{"key":"5257228_CR3","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJM199608223350802","volume":"335","author":"E Hylek","year":"1996","unstructured":"Hylek E, Skates S, Sheehan M, Singer D: An analysis of the lowest effective intensity of prophylactic anticoagulation for patients with nonrheumatic atrial fibrillation. NEngl JMed 1996;335:540\u2013546.","journal-title":"NEngl JMed"},{"key":"5257228_CR4","doi-asserted-by":"crossref","unstructured":"Adjusted-dosewarfarin versus low-intensity, fixed dosewarfarin plus aspirin for high risk patients with atrial fibrillation: Stroke Prevention in Atrial Fibrillation III randomized clinical trial. Lancet 1996;348:633\u2013638.","DOI":"10.1016\/S0140-6736(96)03487-3"},{"key":"5257228_CR5","doi-asserted-by":"crossref","first-page":"492","DOI":"10.7326\/0003-4819-131-7-199910050-00003","volume":"131","author":"RG Hart","year":"1999","unstructured":"Hart RG, Benavente O, McBride R, Pearce LA: Antithrombotic therapy to prevent stroke in patients with atrial fibrillation. Ameta-analysis. Ann Intern Med 1999;131:492\u2013501.","journal-title":"Ann Intern Med"},{"key":"5257228_CR6","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.285.22.2864","volume":"285","author":"B Gage","year":"2001","unstructured":"Gage B, Waterman A, Shannon W, Validation of clinical classification schemes for predicting stroke: Results from the national registry of atrial fibrillation. JAMA 2001;285:2864\u20132870.","journal-title":"JAMA"},{"key":"5257228_CR7","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0002-9343(98)00198-3","volume":"105","author":"RJ Beyth","year":"1998","unstructured":"Beyth RJ, Quinn ML, Landefeld S. Prospective evaluation of an index for predicting the risk of major bleeding in outpatients treated with warfarin. Am J Med 1998;105:91\u201399.","journal-title":"Am J Med"},{"key":"5257228_CR8","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1056\/NEJMoa021328","volume":"347","author":"DG Wyse","year":"2002","unstructured":"Wyse DG, Waldo AL, DiMarco JP, Domanski MJ, Rosenberg Y, Schron EB, Kellen JC, Greene HL, Mickel MC, Dalquist JE, Corley SD. Atrial fibrillation follow-up investigation of rhythm management (AFFIRM) investigators. N Engl J Med 2002;347:1825\u20131833.","journal-title":"N Engl J Med"},{"issue":"6","key":"5257228_CR9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1161\/01.STR.30.6.1223","volume":"30","author":"RG Hart","year":"1999","unstructured":"Hart RG, Pearce LA, McBride R, Rothbart RM, Asinger RW. Factors associated with ischemic stroke during aspirin therapy in atrial fibrillation: Analysis of 2012 participants in the SPAF I-III clinical trials. The Stroke Prevention in Atrial Fibrillation (SPAF) Investigators. Stroke 1999;30(6):1223\u20131229.","journal-title":"Stroke"}],"container-title":["Cardiac Electrophysiology Review"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CEPR.0000023142.88884.d8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/B:CEPR.0000023142.88884.d8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/B:CEPR.0000023142.88884.d8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T17:24:10Z","timestamp":1751822650000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/B:CEPR.0000023142.88884.d8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,12]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2003,12]]}},"alternative-id":["5257228"],"URL":"https:\/\/doi.org\/10.1023\/b:cepr.0000023142.88884.d8","relation":{},"ISSN":["1385-2264","1573-725X"],"issn-type":[{"type":"print","value":"1385-2264"},{"type":"electronic","value":"1573-725X"}],"subject":[],"published":{"date-parts":[[2003,12]]}}}